Our findings reveal details of a role for BP1 in caspase-dependent and bcl-2-linked mechanisms of tumor cell survival, and suggest BP1 could serve as a marker for drug resistance and a therapeutic target. This evidence concerns the gene BCL2 and neoplasm.